Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668551 | SCV000793172 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-07-31 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001075854 | SCV001241493 | likely pathogenic | Retinal dystrophy | 2019-08-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855501 | SCV002304477 | pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 4795 of the USH2A protein (p.Leu4795Arg). This variant is present in population databases (rs199851839, gnomAD 0.002%). This missense change has been observed in individuals with autosomal recessive retinitis pigmentosa and/or Usher syndrome (PMID: 18273898, 27957503, 34203967; Invitae). ClinVar contains an entry for this variant (Variation ID: 553162). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt USH2A protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001855501 | SCV002499959 | uncertain significance | not provided | 2022-02-10 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 18273898, 27957503) |
Baylor Genetics | RCV000678645 | SCV004200709 | pathogenic | Retinitis pigmentosa 39 | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000678645 | SCV000804735 | uncertain significance | Retinitis pigmentosa 39 | 2016-09-01 | no assertion criteria provided | clinical testing |